Home | Welcome to Contract Pharma   
Last Updated Monday, September 22 2014
Print

Frontage Expands Development Services



Published April 3, 2013
Frontage Laboratories has received approval to expand its U.S. Drug Enforcement Agency (DEA) license to include formulation development and manufacture of GMP clinical trial materials (CTM) for pain therapeutics and controlled-substances. For the expanded DEA license, Frontage upgraded its facilities, security, and personnel procedures at both of its Exton, PA sites.
 
Frontage supports companies developing DEA Schedules I–V controlled substances and provides analytical development and GMP analytical testing, clinical trial services and bioanalytical support of clinical and preclinical samples.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On